Indefinite Delivery Contract 75Q80125D00002

Award Date 7/1/25
Last Date to Order 6/30/30
Federal Agency
AHRQ Headquarters
Ultimate Awardee
Not listed
Federal Contract Vehicle
Pricing Type
Order Dependent (IDV only)
Legislative Mandate
Not listed
National Interest Action
None
Award Type
Multiple
Primary Consortia Member
Not listed
Similar IDVs
This indefinite delivery contract (IDC) with the Agency for Healthcare Research and Quality (AHRQ) is for Evidence-Based Practice Center (EPC) services to provide a variety of evidence synthesis products. The contract holder will respond to task orders from AHRQ and other federal partners to produce reports such as systematic reviews, scoping reviews, living reviews, rapid reviews, and qualitative evidence synthesis across medical specialties. The contract is a multiple award IDIQ with a $90...
This Indefinite Delivery Contract (IDC) award by the Agency for Healthcare Research and Quality (AHRQ) to Kaiser Foundation Hospitals aims to procure evidence synthesis services for AHRQ's Evidence-based Practice Center (EPC) program. The $90 million, multiple-award IDC has a period of performance from November 2024 to November 2029. The contract requires the prime contractor to provide a range of evidence synthesis products including systematic reviews, scoping reviews, living reviews, rapid...
The Department of Health and Human Services (HHS) awarded an Indefinite Delivery Contract (IDC) to the Emergency Care Research Institute (ECRI), a nonprofit organization, to provide OTHER PROFESSIONAL SERVICES. The single-award IDC has an unlimited ceiling value and a period of performance through August 30, 2017. ECRI has been contracted to deliver a wide range of specialized healthcare-related services to various federal agencies, including the Department of Veterans Affairs, Agency for...
Emergency Care Research Institute (Ecri) was awarded an indefinite delivery/indefinite quantity contract from the Department of Health and Human Services Centers for Medicare and Medicaid Services to serve as one of multiple prime contractors under the Network of Quality Improvement and Innovation Contractors multiple award IDIQ. With a potential value of $1,000,000 and period of performance from February 2019 through January 2024, this award positions Ecri to receive task orders supporting...
This federal contract IDV award, valued at up to $350,000,000, was issued by the Health Resources and Services Administration (HRSA) to provide a contract mechanism for evidence building and evaluation services. The single-award Indefinite Delivery Indefinite Quantity (IDIQ) contract has a period of performance of one base year with four one-year options, and is not set aside for any specific business type. The contract covers four key task areas: 1) Program Evaluations, 2) Other Evidence...
The Agency for Healthcare Research and Quality (AHRQ), a civilian agency within the U.S. Department of Health and Human Services, awarded an indefinite-delivery, indefinite-quantity (IDIQ) master contract to Oregon Health & Science University (OHSU) called the Evidence-based Practice Centers VI (EPC VI) contract. The contract has a ceiling value of $0.00, allowing AHRQ to issue task orders to OHSU as needed. The EPC VI contract is for OHSU, a prominent research university and academic...
The Federal Contract IDV award is for an Indefinite Delivery Contract (IDC) titled "EVALUATIONS AND EVIDENCE BUILDING IDIQ" with a ceiling value of $350,000,000 over a period of 5 years. The contract was awarded by the Health Resources and Services Administration (HRSA), a civilian federal agency, to Mathematica Inc., a woman-owned business. The purpose of this IDC is to provide HRSA with a contract mechanism to facilitate the production of relevant, high-priority, and robust...
The Federal Supply Schedule contract GS10F063CA was awarded by the General Services Administration (GSA) to the Emergency Care Research Institute (Ecri), a nonprofit organization, to provide a range of healthcare-related services to federal agencies. The contract vehicle allows government agencies to issue task orders for Ecri's expertise in areas such as medical device evaluations, patient safety and risk management, clinical informatics, evidence reviews, and comparative effectiveness...
The Indefinite Delivery Contract (IDC) No. 75Q80120D00017 was awarded by the Agency for Healthcare Research and Quality (AHRQ), a civilian federal agency, to Medstar Health Research Institute Inc. (a non-profit organization) as part of the Accelerating Change and Transformation in Organizations and Networks IV (ACTION IV) IDIQ contract vehicle. This multiple-award IDC, with a ceiling value of $5 million and a period of performance through May 2025, allows AHRQ to issue task orders for a...
This Indefinite Delivery Contract (IDC) was awarded by the Health Resources and Services Administration (HRSA), a civilian federal agency, to the prime contractor Customer Value Partners, LLC. The $350 million ceiling value IDC runs through September 2025 and is intended to provide a contract vehicle for HRSA to obtain a range of evidence-building and evaluation services. The contracted services are organized into four key task areas: (1) conducting program evaluations, (2) performing other...

The federal contract IDV award is for the Agency for Healthcare Research and Quality's (AHRQ) Evidence-based Practice Center (EPC) VII program. The $90 million, multiple-award IDIQ contract has a period of performance from July 2025 to June 2030. The prime contractor, Emergency Care Research Institute (Ecri), is a non-profit organization that provides healthcare quality and safety services to federal agencies.

Under this IDV, Ecri will deliver a variety of evidence synthesis products, including systematic reviews, scoping reviews, living reviews, rapid reviews, and qualitative evidence synthesis. These reports will cover a range of medical specialties and address topics such as treatment effectiveness, prevention, healthcare delivery, health equity, and implementation. The work supports AHRQ's mission to improve healthcare quality, safety, and effectiveness, and informs clinical guidelines, policies, and research agendas for federal agencies, guideline developers, clinicians, patients, and other stakeholders. The contract was competitively awarded without any set-asides.

Generated 6/21/25, 9:45 AM